Quality of Life - the Primary Component in Senior Health Care

Sign Up

September 9th, 2014

Wockhardt Recalls Blood Pressure Drug

Wockhardt Recalls BP Drug


September 2, 2014

The U.S. Food and Drug Administration (FDA) announced on Friday that Wockhardt has initiated a voluntary recall of its high blood pressure medication.

Wockhardt is pulling more than 11,500 high density polyethylene plastic bottles of metoprolol succinate (Toprol-XL). This is the third recall this year. This most recent recall is due to failing a dissolution test.

In April, the Indian drugmaker recalled more than 100,000 bottles of metoprolol succinate for the same reason.  After the FDA discovered manufacturing violations, two of the company’s manufacturing sites were been banned from exporting to the United States, Reuters reported.


1. Wockhardt Recalls More Than 11,60Wockhardt Recalls More Than 11,600 Bottles of Generic Toprol-XL [press release]. FDANews. 2014 Aug 29.

2. Reuters staff. Wockhardt Recalls over 109,000 Bottles of Hypertension Drug in U.S. Pharmacy Learning Network. 2014 May 15.

3. Kanungo S. Wockhardt recalls same drug for third time in the US since May. dna. www.dnaindia.com. 2014 Sept 1.

PLN Topics:
Medication Errors
Compounding Pharmacy Recall
Parkinson’s Drug Recall
Massive Antibiotic Recall
Antibiotic Recall Due to Particulate Matter
Apotex Recalls One Lot of Organ Rejection Drug Due to Label Error

Geriatric Nutrition

Without good nutrition, positive drug therapy outcomes are very difficult to obtain, For the best in Geriatric Nutritional Information

Find out more Optima Solutions

Continuing Education

Each month we will post an analysis of specific aspects of government long-term healthcare regulations.

Find out more